163 related articles for article (PubMed ID: 23240667)
41. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Kuschel B; Lux MP; Goecke TO; Beckmann MW
Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
[TBL] [Abstract][Full Text] [Related]
42. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
[TBL] [Abstract][Full Text] [Related]
43. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
44. [Epidemiology and genetics of cancers of the ovary].
Vidal V; Bignon YJ
Rev Prat; 1997 Jun; 47(11):1182-6. PubMed ID: 9238812
[TBL] [Abstract][Full Text] [Related]
45. [Genetic predisposition and ovarian cancer].
Coupier I; Gauthier-Villars M; This P; Stoppa-Lyonnet D
Rev Prat; 2004 Oct; 54(16):1757-62. PubMed ID: 15630879
[TBL] [Abstract][Full Text] [Related]
46. Hereditary ovarian tumour syndromes: current update on genetics and imaging.
Shanbhogue KP; Prasad AS; Ucisik-Keser FE; Katabathina VS; Morani AC
Clin Radiol; 2021 Apr; 76(4):313.e15-313.e26. PubMed ID: 33353730
[TBL] [Abstract][Full Text] [Related]
47. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.
O'Donovan PJ; Livingston DM
Carcinogenesis; 2010 Jun; 31(6):961-7. PubMed ID: 20400477
[TBL] [Abstract][Full Text] [Related]
48. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
49. Should we be more aware of endometrial cancer in adolescents?
Gałczyński K; Nowakowski Ł; Rechberger T; Semczuk A
Dev Period Med; 2016; 20(3):169-173. PubMed ID: 27941184
[TBL] [Abstract][Full Text] [Related]
50. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
51. Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma.
Kim YT; Nam EJ; Yoon BS; Kim SW; Kim SH; Kim JH; Kim HK; Koo JS; Kim JW
Gynecol Oncol; 2005 Dec; 99(3):585-90. PubMed ID: 16084575
[TBL] [Abstract][Full Text] [Related]
52. Strategies for ovarian cancer prevention.
Dann RB; Kelley JL; Zorn KK
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
[TBL] [Abstract][Full Text] [Related]
53. Gynecological lesions in hereditary cancer predisposition syndromes.
Dundr P; Cibula D; Foretová L; Macek M; Kopečková K; Petruželka L; Němejcová K; Bártů M; Hojný J; Hájková N; Jakša R; Janega P; Stružinská I
Cesk Patol; 2021; 57(2):96-104. PubMed ID: 34275319
[TBL] [Abstract][Full Text] [Related]
54. Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.
Bercow AS; Eisenhauer EL
J Surg Oncol; 2019 Oct; 120(5):864-872. PubMed ID: 31355450
[TBL] [Abstract][Full Text] [Related]
55. Genetics of gynaecological cancers.
Constantinou P; Tischkowitz M
Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():114-124. PubMed ID: 28202331
[TBL] [Abstract][Full Text] [Related]
56. Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers.
Manchanda R; Rosenthal A; Burnell M; Fraser L; Mackay J; Skates S
J Med Genet; 2009 Jun; 46(6):423-4. PubMed ID: 19487541
[No Abstract] [Full Text] [Related]
57. Hereditary ovarian cancers: state of the art.
Toss A; Molinaro E; Sammarini M; Del Savio MC; Cortesi L; Facchinetti F; Grandi G
Minerva Med; 2019 Aug; 110(4):301-319. PubMed ID: 31081309
[TBL] [Abstract][Full Text] [Related]
58. Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.
Viswanathan AN; Buttin BM; Kennedy AM
Radiographics; 2008; 28(1):289-307. PubMed ID: 18444279
[No Abstract] [Full Text] [Related]
59. Counselling and management of women with genetic predisposition to gynaecological cancers.
Malik N; Sahu B
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():44-48. PubMed ID: 38215600
[TBL] [Abstract][Full Text] [Related]
60. [Circulating tumor DNA assessment for gynaecological cancers management].
Mari R; Lambaudie É; Provansal M; Sabatier R
Bull Cancer; 2019 Mar; 106(3):237-252. PubMed ID: 30765097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
